New Bone-Strengthening Drug Abaloparatide Approved for Post-Menopausal Women by NHS

Tens of thousands of post-menopausal women could benefit from Abaloparatide, a new bone-strengthening drug approved by NICE for NHS use in England, BBC News reports. Abaloparatide can protect against osteoporosis, a bone-thinning condition that increases the risk of fractures in older women.